טוען...
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
Glioma is the most common and aggressive tumor type of the central nervous system and is associated with poor prognosis. To date, novel emerging immunotherapies have significantly improved outcomes for patients with various cancer types. Human endogenous retrovirus-H long terminal repeat-associating...
שמור ב:
| הוצא לאור ב: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826309/ https://ncbi.nlm.nih.gov/pubmed/31578594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7343 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|